An Automated Detection System of Drug-Drug Interactions from Electronic Patient Records Using Big Data Analytics
Author(s) -
Guillaume Bouzillé,
Camille Morival,
Richard Westerlynck,
Pierre Lemordant,
Emmanuel Chazard,
Pascal Le Corre,
Yann Busnel,
Marc Cuggia
Publication year - 2019
Publication title -
studies in health technology and informatics
Language(s) - English
Resource type - Journals
eISSN - 1879-8365
pISSN - 0926-9630
DOI - 10.3233/shti190180
Subject(s) - pharmacovigilance , computer science , analytics , big data , drug , data warehouse , spark (programming language) , health records , medical record , data science , medical emergency , database , data mining , medicine , health care , pharmacology , radiology , economics , programming language , economic growth
The aim of the study was to build a proof-of-concept demonstratrating that big data technology could improve drug safety monitoring in a hospital and could help pharmacovigilance professionals to make data-driven targeted hypotheses on adverse drug events (ADEs) due to drug-drug interactions (DDI). We developed a DDI automatic detection system based on treatment data and laboratory tests from the electronic health records stored in the clinical data warehouse of Rennes academic hospital. We also used OrientDb, a graph database to store informations from five drug knowledge databases and Spark to perform analysis of potential interactions betweens drugs taken by hospitalized patients. Then, we developed a machine learning model to identify the patients in whom an ADE might have occurred because of a DDI. The DDI detection system worked efficiently and computation time was manageable. The system could be routinely employed for monitoring.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom